| From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus K Musunuru, A Strong, M Frank-Kamenetsky, NE Lee, T Ahfeldt, KV Sachs, ... Nature 466 (7307), 714-719, 2010 | 1237 | 2010 |
| Permanent alteration of PCSK9 with in vivo CRISPR-Cas9 genome editing Q Ding, A Strong, KM Patel, SL Ng, BS Gosis, SN Regan, CA Cowan, ... Circulation research 115 (5), 488-492, 2014 | 584 | 2014 |
| Hepatic sortilin regulates both apolipoprotein B secretion and LDL catabolism A Strong, Q Ding, AC Edmondson, JS Millar, KV Sachs, X Li, A Kumaravel, ... The Journal of clinical investigation 122 (8), 2807-2816, 2012 | 240 | 2012 |
| Targeted treatment of migrating partial seizures of infancy with quinidine D Bearden, A Strong, J Ehnot, M DiGiovine, D Dlugos, EM Goldberg Annals of neurology 76 (3), 457-461, 2014 | 236 | 2014 |
| Macrophage sortilin promotes LDL uptake, foam cell formation, and atherosclerosis KM Patel, A Strong, J Tohyama, X Jin, CR Morales, J Billheimer, J Millar, ... Circulation research 116 (5), 789-796, 2015 | 201 | 2015 |
| Activation of ER stress and mTORC1 suppresses hepatic sortilin-1 levels in obese mice D Ai, JM Baez, H Jiang, DM Conlon, A Hernandez-Ono, ... The Journal of clinical investigation 122 (5), 1677-1687, 2012 | 111 | 2012 |
| Genome editing in cardiovascular diseases A Strong, K Musunuru Nature Reviews Cardiology 14 (1), 11-20, 2017 | 102 | 2017 |
| Sortilin and lipoprotein metabolism: making sense out of complexity A Strong, K Patel, DJ Rader Current opinion in lipidology 25 (5), 350-357, 2014 | 92 | 2014 |
| Sortilin as a regulator of lipoprotein metabolism A Strong, DJ Rader Current atherosclerosis reports 14, 211-218, 2012 | 60 | 2012 |
| Autophagy is required for sortilin-mediated degradation of apolipoprotein B100 J Amengual, L Guo, A Strong, J Madrigal-Matute, H Wang, S Kaushik, ... Circulation research 122 (4), 568-582, 2018 | 42 | 2018 |
| Returning integrated genomic risk and clinical recommendations: The eMERGE study JE Linder, A Allworth, HT Bland, PJ Caraballo, RL Chisholm, EW Clayton, ... Genetics in Medicine 25 (4), 100006, 2023 | 40 | 2023 |
| Clinical implications of lipid genetics for cardiovascular disease A Strong, DJ Rader Current cardiovascular risk reports 4, 461-468, 2010 | 32 | 2010 |
| De novo loss-of-function variants in X-linked MED12 are associated with Hardikar syndrome in females D Li, A Strong, KM Shen, D Cassiman, M Van Dyck, ND Linhares, ... Genetics in Medicine 23 (4), 637-644, 2021 | 24 | 2021 |
| EP300‐related Rubinstein–Taybi syndrome: Highlighted rare phenotypic findings and a genotype–phenotype meta‐analysis of 74 patients JL Cohen, SA Schrier Vergano, S Mazzola, A Strong, B Keena, ... American Journal of Medical Genetics Part A 182 (12), 2926-2938, 2020 | 23 | 2020 |
| Persistent dyslipidemia in treatment of lysosomal acid lipase deficiency AB Pritchard, A Strong, C Ficicioglu Orphanet Journal of Rare Diseases 15, 1-7, 2020 | 15 | 2020 |
| Delayed diagnosis and racial bias in children with genetic conditions J Omorodion, L Dowsett, RD Clark, J Fraser, A Abu‐El‐Haija, A Strong, ... American Journal of Medical Genetics Part A 188 (4), 1118-1123, 2022 | 14 | 2022 |
| Stankiewicz-Isidor syndrome: expanding the clinical and molecular phenotype B Isidor, F Ebstein, A Hurst, M Vincent, I Bader, NL Rudy, B Cogne, J Mayr, ... Genetics in Medicine 24 (1), 179-191, 2022 | 14 | 2022 |
| Perspectives of rare disease experts on newborn genome sequencing NB Gold, SM Adelson, N Shah, S Williams, SL Bick, ES Zoltick, JI Gold, ... JAMA Network Open 6 (5), e2312231-e2312231, 2023 | 13 | 2023 |
| Ocular manifestations of ectodermal dysplasia D Landau Prat, WR Katowitz, A Strong, JA Katowitz Orphanet Journal of Rare Diseases 16 (1), 197, 2021 | 13 | 2021 |
| Rare variants in KDR, encoding VEGF Receptor 2, are associated with tetralogy of Fallot D Škorić-Milosavljević, N Lahrouchi, FM Bosada, G Dombrowsky, ... Genetics in Medicine 23 (10), 1952-1960, 2021 | 12 | 2021 |
